Lista de obras - Kirsten Palmer - Dominio Público Uruguay

Accurately predicting the risk of serious maternal morbidity in preterm preeclampsia: Can It be done?

artículo científico publicado en 2018

Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia

artículo científico publicado en 2018

Association Between Twin Discordance at 6–9 Weeks' of Gestation and Birthweight Complications

artículo científico publicado en 2010

Changes in the modes of twin birth in Victoria, 1983-2015

artículo científico publicado en 2019

Comparison of maternal and perinatal outcomes in women with super obesity based on planned mode of delivery

scientific article published on 13 August 2018

Current and emerging pharmacotherapy for emergency management of preeclampsia

artículo científico publicado en 2019

EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion

artículo científico publicado en 2019

Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta-Analysis

artículo científico publicado en 2019

Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia

artículo científico publicado en 2005

Inter-twin delivery interval, short-term perinatal outcomes and risk of caesarean for the second twin

scientific article published on 08 August 2018

Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study

artículo científico publicado en 2011

Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.

artículo científico publicado en 2016

Letter to the Editor: Backbone 1H, 13C and 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2)

artículo científico publicado en 2005

MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

artículo científico publicado en 2012

MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin

artículo científico publicado en 2012

MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production

artículo científico publicado en 2012

Management of intrahepatic cholestasis in pregnancy

scientific article published on 14 February 2019

Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.

artículo científico publicado en 2016

Measurement of mRNA Transcripts of Very High Placental Expression in Maternal Blood as Biomarkers of Preeclampsia

artículo científico publicado en 2011

Mechanical methods for induction of labour

scientific article published on 18 October 2019

Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.

artículo científico publicado en 2016

PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia

artículo científico publicado en 2014

PLAC4 is upregulated in severe early onset preeclampsia and upregulated with syncytialisation but not hypoxia

artículo científico publicado en 2013

Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia.

artículo científico publicado en 2011

Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.

artículo científico publicado en 2015

Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis

artículo científico publicado en 2016

Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol

scientific article published on 17 October 2019

Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction

scientific article published on 22 June 2019

Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction

artículo científico publicado en 2017

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.

artículo científico publicado en 2017

Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression.

artículo científico publicado en 2011

Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma

scientific article published on 07 August 2019

The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues

artículo científico publicado en 2005

Too close to call: Uterine closure technique at caesarean section

artículo científico publicado en 2020

Undiagnosed maternal diaphragmatic hernia - a management dilemma.

artículo científico publicado en 2018

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction

artículo científico publicado en 2018

Lista de obras de Kirsten Palmer

Accurately predicting the risk of serious maternal morbidity in preterm preeclampsia: Can It be done?

Assessing the Circulating Placental-Specific Anti-angiogenic Protein sFLT-1 e15a in Preeclampsia

Association Between Twin Discordance at 6–9 Weeks' of Gestation and Birthweight Complications

Changes in the modes of twin birth in Victoria, 1983-2015

Comparison of maternal and perinatal outcomes in women with super obesity based on planned mode of delivery

Current and emerging pharmacotherapy for emergency management of preeclampsia

EGFR (Epidermal Growth Factor Receptor) Signaling and the Mitochondria Regulate sFlt-1 (Soluble FMS-Like Tyrosine Kinase-1) Secretion

Evaluation of Cardiac Function in Women With a History of Preeclampsia: A Systematic Review and Meta-Analysis

Genetic deletion of murine SPRY domain-containing SOCS box protein 2 (SSB-2) results in very mild thrombocytopenia

Inter-twin delivery interval, short-term perinatal outcomes and risk of caesarean for the second twin

Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study

Jumonji Domain Containing Protein 6 Is Decreased in Human Preeclamptic Placentas and Regulates sFLT-1 Splice Variant Production.

Letter to the Editor: Backbone 1H, 13C and 15N assignments of the 25 kDa SPRY domain-containing SOCS box protein 2 (SSB-2)

MMP-14 is expressed in preeclamptic placentas and mediates release of soluble endoglin.

MMP-15 is upregulated in preeclampsia, but does not cleave endoglin to produce soluble endoglin

MT-MMPs in pre-eclamptic placenta: relationship to soluble endoglin production

Management of intrahepatic cholestasis in pregnancy

Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.

Measurement of mRNA Transcripts of Very High Placental Expression in Maternal Blood as Biomarkers of Preeclampsia

Mechanical methods for induction of labour

Nuclear factor of activated T-cells (NFAT) regulates soluble fms-like tyrosine kinase-1 secretion (sFlt-1) from human placenta.

PAPPA2 is increased in severe early onset pre-eclampsia and upregulated with hypoxia

PLAC4 is upregulated in severe early onset preeclampsia and upregulated with syncytialisation but not hypoxia

Placental expression of a novel primate-specific splice variant of sFlt-1 is upregulated in pregnancies complicated by severe early onset pre-eclampsia.

Placental-Specific sFLT-1 e15a Protein Is Increased in Preeclampsia, Antagonizes Vascular Endothelial Growth Factor Signaling, and Has Antiangiogenic Activity.

Placental-specific sFLT-1: role in pre-eclamptic pathophysiology and its translational possibilities for clinical prediction and diagnosis

Prolong: a double-blind randomised placebo-controlled trial of broccoli sprout extract in women with early onset preeclampsia. A clinical trial protocol

Protect-me: a parallel-group, triple blinded, placebo-controlled randomised clinical trial protocol assessing antenatal maternal melatonin supplementation for fetal neuroprotection in early-onset fetal growth restriction

Proton Pump Inhibitors Decrease Soluble fms-Like Tyrosine Kinase-1 and Soluble Endoglin Secretion, Decrease Hypertension, and Rescue Endothelial Dysfunction

Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.

Severe early-onset preeclampsia is not associated with a change in placental catechol O-methyltransferase (COMT) expression.

Stability of placental growth factor, soluble fms-like tyrosine kinase 1, and soluble fms-like tyrosine kinase 1 e15a in human serum and plasma

The SPRY domain of SSB-2 adopts a novel fold that presents conserved Par-4-binding residues

Too close to call: Uterine closure technique at caesarean section

Undiagnosed maternal diaphragmatic hernia - a management dilemma.

Uterine Artery Doppler in Screening for Preeclampsia and Fetal Growth Restriction